A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 4

Conditions: Complicated Intra-abdominal Infection

Treatments: Drug: MK0826; ertapenem sodium; Drug: Comparator: ceftriaxone + metronidazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00157898

2005_068

MK0826-050

0826-050

Details and patient eligibility

About

This was a prospective, randomized, controlled, open, and multi-center trial conducted to compare the clinical efficacy and safety of ertapenem with it's comparator before or following adequate surgical management of complicated intra-abdominal infection.

Enrollment: 134 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Males or females between the ages of 18 and 75 who have complicated intra-abdominal infection.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)